该 SHARE 研究 - 头癌后的生存率:评估在加拿大安大略省的患者护理和随访的坚持:随机对照试验的研究协议
Billy Tran1, Agnieszka Dzioba1,2, Jennifer Baker1
1Department of Otolaryngology-Head and Neck Surgery, London Health Sciences Centre, London, ON, Canada.
Trials
|December 13, 2025
概括
这项研究评估了个性化的治疗总结和幸存者护理计划 (TSSP) 与激励面试 (MI) 以改善头癌 (HNC) 幸存者护理. 这项干预旨在提高患者的治疗结果和医生遵守护理建议.
科学领域:
- 在瘤学瘤学.
- 患者护理管理 患者护理管理
- 医疗保健服务研究 医疗服务研究
背景情况:
- 头癌 (HNC) 幸存者面临长期的身体和心理社会挑战.
- 目前的幸存者护理往往是分散的,导致未满足的患者需求.
- 对HNC幸存者护理的基于证据的指导方针缺乏一致的实施.
研究的目的:
- 评估个性化治疗总结和幸存者护理计划 (TSSP) 与激励面试 (MI) 结合是否可以改善幸存者护理.
- 评估对医生实施护理建议,患者满意度和HNC幸存者的生活质量 (QoL) 的影响.
主要方法:
- 一个前性,随机对照试验 (RCT) 与252名HNC幸存者.
- 干预组接受TSSP和一次性MI会话;对照组接受通常的护理.
- 在基线,3个月,6个月和12个月测量结果,重点关注症状管理和患者满意度.
主要成果:
- 主要结局:12个月后,由初级保健提供者 (PCP) 解决的患者确定的生存问题的比例.
- 二次结果:患者对TSSP,MI,护理,信息,QoL和PCP反的满意度.
- 使用混合效应模型的治疗意向分析将随着时间的推移将组进行比较.
结论:
- 这项研究将提供关于将TSSP和MI整合到HNC幸存者护理中的可行性和有效性的证据.
- 该方法旨在赋予幸存者自我管理的能力,并改善长期健康.
- 结果将为幸存者护理规划和瘤学定制干预提供最佳实践.
相关概念视频
01:21Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
133
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
133
02:20Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
01:15Assumptions of Survival Analysis
382
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
382
01:20Comparing the Survival Analysis of Two or More Groups
533
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
533